Analysts at Berenberg have raised their estimates for the global…

Community

· Jul 11

Analysts at Berenberg have raised their estimates for the global obesity market to $150 billion by 2035, up from $125 billion previously. This revision is the result of positive data on co-morbidities and advances in competing studies. Berenberg recommends buying shares of $LLY and Zealand Pharma, while he recommends holding on to shares of $NVO.

What are your thoughts on this change in estimates and have you invested in any of these companies?

A community member's personal view, not investment advice. Community Guidelines

Bill Combs @billcombs Jul 14

This sector currently has great potential. However, shares in this sector are already quite expensive. I bought $NVO and I don't regret it.

Ashraf Aboudar @ashraf_dd Jul 12

Honestly I'm not surprised this is happening People have settled down a lot in and after covid and are moving less, at least I think so. Fastfoods are still growing and more people are choosing them more often. It could be a really interesting sector.

⌘ K

StockBot Live

Market situation Wall Street

Wall Street slides as Treasury yields near 5%

The S&P 500 fell -0.21% and the Dow -0.44%. Rising Treasury yields near 5% erased earlier tech-driven gains.

Ask about this

StockBot knows 80,000+ stocks worldwide

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.